Clinical nephrotoxicity of tobramycin and gentamicin. A prospective study.

Abstract

Nearly 3.2 million people in this country receive aminoglycoside antibiotics annually. Gentamicin sulfate and tobramycin sulfate continue to demonstrate ototoxicity and nephrotoxicity in both animal and clinical studies. In this study, 62 patients with confirmed initial normal renal function and treated with 2 to 5 mg/kg/day of gentamicin sulfate or… (More)

Topics

Cite this paper

@article{Kumin1980ClinicalNO, title={Clinical nephrotoxicity of tobramycin and gentamicin. A prospective study.}, author={G D Kumin}, journal={JAMA}, year={1980}, volume={244 16}, pages={1808-10} }